PREDICTORS OF RESPONSE FOLLOWING NEOADJUVANT CISPLATIN BASED CHEMOTHERAPY FOR MUSCLE INVASIVE UROTHELIAL BLADDER CANCER USING MOLECULAR PROFILE

被引：0
|
作者：
Elkarta, Ahmed
Elhefnawy, Ahmed
Abol-Enein, Hassan
Shokeir, Ahmed
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP56-07
引用
收藏
页码：E974 / E974
页数：1
相关论文
共 50 条
  • [1] Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective Clinical Study
    Elkarta, Ahmed
    Awadalla, Amira
    El-hefnawy, Ahmed
    Mosbah, Ahmed
    Abolenein, Hassan
    Shokeir, Ahmed
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 38 - 46.e1
  • [2] A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Degener, Stephan
    Mata, Douglas A.
    Youssef, Ramy
    Goedde, Daniel
    Tandogdu, Zafer
    Roth, Stephan
    von Rundstedt, Friedrich-Carl
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1133 - 1142
  • [3] MOLECULAR PREDICTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER
    Ragonese, Mauro
    Di Gianfrancesco, Luca
    Schinzari, Giovanni
    Palermo, Giuseppe
    Racioppi, Marco
    Bassi, PierFrancesco
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1024 - E1025
  • [4] Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
    Lee, Franklin C.
    Harris, William
    Cheng, Heather H.
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael
    Yu, Evan Y.
    Wright, Jonathan L.
    ADVANCES IN UROLOGY, 2013, 2013
  • [5] Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts
    Tse, Jennifer
    Ghandour, Rashed
    Singla, Nirmish
    Lotan, Yair
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04)
  • [6] Multidisciplinary management and use of neoadjuvant cisplatin combination chemotherapy in patients with muscle-invasive urothelial bladder cancer
    Hoffman-Censits, Jean H.
    Lin, Jianqing
    Lallas, Costas D.
    Showalter, Timothy Norman
    Den, Robert Benjamin
    Doubet, Ellen
    Brown, Jillian
    Singh, Jaspreet
    Dicker, Adam
    Gomella, Leonard G.
    Kelly, William Kevin
    Trabulsi, Edouard John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Guancial, Elizabeth A.
    Kilari, Deepak
    Xiao, Guang-Qian
    Abu-Farsakh, Sohaib H.
    Baran, Andrea
    Messing, Edward M.
    Kim, Eric S.
    PLOS ONE, 2016, 11 (05):
  • [8] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
    Kim, Hongsik
    Jeong, Byong Chang
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Pyo, Hongryull
    Song, Wan
    Sung, Hyun Hwan
    Hong, Jung Yong
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642
  • [9] Identifying predictors of pathologic complete response to neoadjuvant chemotherapy for muscle invasive bladder cancer.
    Harzstark, Andrea
    Merchant, Maqdooda
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Muscle-invasive bladder cancer: Molecular subtypes and response to neoadjuvant chemotherapy.
    Seiler, Roland
    Winters, Brian
    Douglas, James
    van Rhijn, Bas W. G.
    Sjodahl, Gottfrid
    Lerner, Seth P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345